Amphotericin B liposomal

Kathryn Dzintars, Pharm.D., BCPS, Paul A. Pham, Pharm.D.
Pediatric Dosing Author: Alice Jenh Hsu, PharmD, BCPS, AQ-ID

INDICATIONS

FDA

  • Aspergillosis (in patients refractory to or intolerant of amphotericin B deoxycholate)
  • Candidiasis (in patients refractory to or intolerant of amphotericin B deoxycholate)
  • Cryptococcosis (in patients refractory to or intolerant of amphotericin B deoxycholate)
  • Empiric therapy for presumed fungal infection in patients with febrile neutropenia
  • Visceral leishmaniasis

NON-FDA APPROVED USES

  • Zygomycetes and other invasive molds
  • Coccidioidomycosis
  • Histoplasmosis

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: February 26, 2017